Flurbiprofen 60% SR Pellets are an important multiparticulate dosage-form option for pharmaceutical companies developing sustained-release formulations. For businesses evaluating Flurbiprofen Manufacturers and Suppliers in India, understanding the characteristics, manufacturing considerations, and applications of these pellets can help in selecting a suitable pharmaceutical partner. Jenerx Pharma offers Flurbiprofen SR Pellets in 60% and 66% strengths as part of its pharmaceutical pellet portfolio.
What Are Flurbiprofen 60% SR Pellets?
Flurbiprofen is a non-steroidal anti-inflammatory drug (NSAID) associated with anti-inflammatory and analgesic formulations. In an SR, or sustained-release, pellet system, the active ingredient is incorporated into multiparticulate units designed to provide controlled drug release over a defined period.
Unlike a conventional immediate-release system, sustained-release pellets are developed with formulation and coating characteristics that influence the rate at which the active ingredient becomes available. This makes pellet technology useful for pharmaceutical developers seeking controlled-release characteristics in oral dosage forms.
Jenerx describes its Flurbiprofen SR Pellets as pharmaceutical-grade sustained-release pellets intended for oral dosage formulations such as capsules and modified-release systems.
Key Features of Flurbiprofen 60% SR Pellets
1. Sustained-Release Characteristics
The primary feature of Flurbiprofen 60% SR Pellets is their controlled-release design. The release profile is influenced by factors such as pellet characteristics, coating technology, formulation composition, and manufacturing parameters.
A well-controlled release profile can provide formulation developers with greater flexibility when designing oral dosage products.
2. Multiparticulate Dosage Form
Pellets are small, free-flowing multiparticulate systems. Their physical characteristics can offer advantages during capsule filling and other pharmaceutical formulation processes.
Because pellets can be incorporated into different dosage-form designs, they provide flexibility for pharmaceutical development teams.
3. Defined Drug Loading
A 60% strength represents the specified drug loading of the pellet product. Consistent drug content is an important consideration when pharmaceutical companies evaluate a pellet supplier because variations can affect dosage uniformity and finished-product performance.
4. Controlled Drug Release
The release characteristics of SR pellets are determined through formulation design and manufacturing controls. Coating thickness, coating composition, pellet size, process parameters, and other formulation variables can influence dissolution behavior.
Consequently, appropriate analytical testing and process control are important for achieving consistent batch-to-batch performance.
5. Pharmaceutical Manufacturing Flexibility
Multiparticulate pellet technology can be incorporated into oral pharmaceutical dosage forms, particularly capsules and modified-release systems. This provides formulation teams with an alternative to conventional single-unit dosage forms.
Applications of Flurbiprofen 60% SR Pellets
Flurbiprofen SR pellets are primarily relevant to pharmaceutical formulations where sustained-release delivery is required. Jenerx identifies applications associated with anti-inflammatory and pain-relief formulations and notes their relevance to pharmaceutical manufacturers, formulation development teams, research organizations, CDMOs, and export-oriented pharmaceutical businesses.
Oral Modified-Release Formulations
One of the key applications is the development of oral dosage forms requiring controlled release. Pellets may be incorporated into capsules or other pharmaceutical systems according to the formulation requirements.
Formulation Development
Pharmaceutical R&D teams can use sustained-release pellets as a semi-finished dosage-form component during product development. Their multiparticulate structure allows developers to work with defined release characteristics while optimizing the finished dosage form.
Commercial Pharmaceutical Manufacturing
After successful formulation development and appropriate quality evaluation, SR pellets can be considered for commercial pharmaceutical manufacturing. Consistency in drug content, particle-size distribution, dissolution behavior, and other quality attributes becomes increasingly important during scale-up.
Quality Considerations When Selecting a Supplier
For pharmaceutical companies searching for Flurbiprofen Manufacturers and Suppliers in India, product quality should be evaluated alongside manufacturing capability and documentation.
Important considerations may include:
- Assay and drug-content consistency
- Dissolution and release-profile testing
- Particle-size distribution
- Moisture-related parameters
- Impurity evaluation
- Packaging and storage conditions
- Batch-to-batch consistency
- Technical and regulatory documentation
Jenerx states that its analytical evaluation of Flurbiprofen SR Pellets can include assay, dissolution profiling, moisture determination, impurity analysis, and particle-size distribution assessment.
Why Pellet Manufacturing Expertise Matters
Sustained-release pellets require controlled manufacturing processes because physical and formulation variables can influence final release characteristics. Uniform coating, appropriate process controls, and in-process quality monitoring can contribute to reproducible pellet performance.
Jenerx Pharma describes its manufacturing facility as GMP certified and states that its controlled-release pellet manufacturing operates under quality assurance and quality-control parameters. The company also reports experience in pellet formulation development and commercial manufacturing.
For buyers comparing Flurbiprofen Manufacturers and Suppliers in India, this combination of product knowledge, quality systems, documentation, and manufacturing capacity can be important when moving from development quantities to commercial supply.
Flurbiprofen 60% SR Pellets for Pharmaceutical Supply
Selecting the appropriate pellet strength and release profile depends on the requirements of the finished pharmaceutical formulation. Therefore, buyers should discuss technical specifications, analytical requirements, packaging, documentation, minimum order quantities, and intended application with the manufacturer before placing a commercial order.
Jenerx Pharma lists Flurbiprofen SR Pellets at both 60% and 66% strengths and provides pellet manufacturing capabilities for domestic and international pharmaceutical markets. Its broader pellet portfolio includes sustained-release, enteric-coated, modified-release, and other specialized pellet systems.
Conclusion
Flurbiprofen 60% SR Pellets combine the pharmaceutical properties of flurbiprofen with multiparticulate sustained-release technology. Their defined drug loading, controlled-release characteristics, and compatibility with oral modified-release formulations make them a useful option for pharmaceutical formulation and manufacturing applications.
For companies sourcing these products, evaluating the manufacturer’s quality systems, analytical capabilities, technical documentation, manufacturing infrastructure, and supply reliability is essential. Choosing experienced Flurbiprofen Manufacturers and Suppliers in India can help pharmaceutical companies identify a supply partner aligned with their formulation-development and commercial manufacturing requirements.
Other Recommendations: Dexlansoprazole Pellets Manufacturers in India
